Health Related Quality of Life in LCIG Patients and LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy. A Multicenter Post Marketing Observational Study for LCIG in Germany and Switzerland - BALANCE
Phase of Trial: Phase IV
Latest Information Update: 21 Feb 2018
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms BALANCE
- Sponsors AbbVie
- 15 Feb 2018 Planned End Date changed from 16 Dec 2018 to 31 Dec 2019.
- 15 Feb 2018 Planned primary completion date changed from 16 Dec 2018 to 31 Dec 2019.
- 02 Jun 2017 Planned number of patients changed from 250 to 266.